{"title": "Eficacia y seguridad de Guduchi Ghan Vati para pacientes asintom\u00e1ticos de Covid-19", "author": null, "url": "https://ichgcp.net/es/clinical-trials-registry/NCT04480398", "hostname": "ichgcp.net", "description": "La enfermedad por coronavirus 2019 (Covid-19) ha sido declarada emergencia mundial con medidas inmediatas de seguridad, preventivas y curativas para controlar l.... Registro de ensayos cl\u00ednicos. ICH GCP.", "sitename": "ichgcp.net", "date": "2020-07-18", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Eficacia y seguridad de Guduchi Ghan Vati para pacientes asintom\u00e1ticos de Covid-19\n[Aarogyam UK](https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Aarogyam%20UK)\nUn estudio retrospectivo sobre la eficacia y seguridad de Guduchi Ghan Vati para pacientes asintom\u00e1ticos de Covid-19\nLa enfermedad por coronavirus 2019 (Covid-19) ha sido declarada emergencia mundial con medidas inmediatas de seguridad, preventivas y curativas para controlar la propagaci\u00f3n del virus. Los casos confirmados se tratan con manejo cl\u00ednico a medida que se diagnostican, pero hasta el momento no existe un tratamiento o vacuna efectivos para el Covid-19.\nCon las pautas recomendadas del Ministerio AYUSH, India, el uso de Ayurveda para Covid-19 ha aumentado; sin embargo, su eficacia y seguridad en pacientes confirmados con Covid-19 siguen sin estar claras.\nEl presente estudio examin\u00f3 la eficacia y seguridad de uno de los medicamentos de Ayurveda recomendados (Guduchi Ghan Vati) en comparaci\u00f3n con la atenci\u00f3n est\u00e1ndar para pacientes con pacientes asintom\u00e1ticos de Covid-19.\nDescripci\u00f3n general del estudio\nEstado\nCondiciones\nIntervenci\u00f3n / Tratamiento\nTipo de estudio\nInscripci\u00f3n (Actual)\nContactos y Ubicaciones\nUbicaciones de estudio\n-\nIndia\n-\nRajasthan\n-\nJodhpur, Rajasthan, India\n- Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University\n-\n-\nCriterios de participaci\u00f3n\nCriterio de elegibilidad\nEdades elegibles para estudiar\nAcepta Voluntarios Saludables\nG\u00e9neros elegibles para el estudio\nM\u00e9todo de muestreo\nPoblaci\u00f3n de estudio\nDescripci\u00f3n\nCriterios de inclusi\u00f3n:\n- Mayores de 18 a\u00f1os\n- Una persona diagnosticada con COVID-19\n- Asintom\u00e1tico en el momento del ingreso\nCriterio de exclusi\u00f3n:\n- Pacientes mayores de 75 a\u00f1os\n- Tomar antibi\u00f3ticos o antirretrovirales por cualquier motivo\n- S\u00edntomas leves a moderados en el momento del ingreso hospitalario\nPlan de estudios\n\u00bfC\u00f3mo est\u00e1 dise\u00f1ado el estudio?\nDetalles de dise\u00f1o\n- Modelos observacionales: Grupo\n- Perspectivas temporales: Retrospectivo\nCohortes e Intervenciones\n|\n|\nGrupo / Cohorte\n|\n|\nIntervenci\u00f3n / Tratamiento\n|\n|\nAyurveda\nGuduchi Ghan Vati se administr\u00f3 a pacientes con Covid 2 tabletas (500 mg cada una) dos veces al d\u00eda por v\u00eda oral despu\u00e9s de las comidas durante 28 d\u00edas. Guduchi ghan vati es un extracto acuoso en polvo de Tinospora cordifolia en forma de tabletas y preparado en la Farmacia de la Universidad certificada por GMP, siguiendo el protocolo est\u00e1ndar.\n|\n|\nGuduchi Ghan Vati es una preparaci\u00f3n cl\u00e1sica ayuv\u00e9dica que se prepara a partir de extracto acuoso de Tinospora cordifolia.\nOtros nombres:\n|\n|\nControl\nLa atenci\u00f3n est\u00e1ndar para los casos asintom\u00e1ticos confirmados es el aislamiento (para contener la transmisi\u00f3n del virus) y el seguimiento cl\u00ednico seg\u00fan las Directrices recomendadas.\n\u00bfQu\u00e9 mide el estudio?\nMedidas de resultado primarias\n|\n|\nMedida de resultado\n|\n|\nMedida Descripci\u00f3n\n|\n|\nPeriodo de tiempo\n|\n|\nAclaramiento virol\u00f3gico\nPeriodo de tiempo: 21 d\u00edas\n|\n|\nEl aclaramiento virol\u00f3gico indica la duraci\u00f3n desde el primer resultado positivo de Covid-19 hasta el primer resultado negativo de Covid-19\n|\n|\n21 d\u00edas\nMedidas de resultado secundarias\n|\n|\nMedida de resultado\n|\n|\nMedida Descripci\u00f3n\n|\n|\nPeriodo de tiempo\n|\n|\nCambio en el n\u00famero de pacientes que pasan de asintom\u00e1ticos a enfermedad moderada\nPeriodo de tiempo: 10 d\u00edas de ingreso hospitalario\n|\n|\ncambio en el n\u00famero de pacientes que pasan de asintom\u00e1ticos a enfermedad moderada\n|\n|\n10 d\u00edas de ingreso hospitalario\n|\n|\nEstancia en el hospital\nPeriodo de tiempo: 21 d\u00edas\n|\n|\nDuraci\u00f3n total de la estancia en el hospital para la recuperaci\u00f3n completa\n|\n|\n21 d\u00edas\n|\n|\nEfectos adversos cl\u00ednicamente relevantes\nPeriodo de tiempo: 21 d\u00edas\n|\n|\nEfectos adversos cl\u00ednicamente relevantes de Guduchi Ghan Vati (incapacidad, molestia notificada)\n|\n|\n21 d\u00edas\nColaboradores e Investigadores\nPatrocinador\nColaboradores\nInvestigadores\n- Silla de estudio: Parashar Sharma, Samta Ayurveda Prakoshtha\n- Silla de estudio: Jaydeep Joshi, Aarogyam UK\nFechas de registro del estudio\nFechas importantes del estudio\nInicio del estudio (Actual)\nFinalizaci\u00f3n primaria (Actual)\nFinalizaci\u00f3n del estudio (Actual)\nFechas de registro del estudio\nEnviado por primera vez\nPrimero enviado que cumpli\u00f3 con los criterios de control de calidad\nPublicado por primera vez (Actual)\nActualizaciones de registros de estudio\n\u00daltima actualizaci\u00f3n publicada (Actual)\n\u00daltima actualizaci\u00f3n enviada que cumpli\u00f3 con los criterios de control de calidad\n\u00daltima verificaci\u00f3n\nM\u00e1s informaci\u00f3n\nT\u00e9rminos relacionados con este estudio\nPalabras clave\nT\u00e9rminos MeSH relevantes adicionales\n-\n[Procesos Patol\u00f3gicos](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pathologic%20Processes)\n-\n[Infecciones por coronavirus](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Coronavirus%20Infections)\n-\n[Infecciones por coronaviridae](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Coronaviridae%20Infections)\n-\n[Infecciones por Nidovirales](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Nidovirales%20Infections)\n-\n[Infecciones por virus de ARN](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=RNA%20Virus%20Infections)\n-\n[Enfermedades virales](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Virus%20Diseases)\n-\n[Infecciones](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Infections)\n-\n[Infecciones del Tracto Respiratorio](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Respiratory%20Tract%20Infections)\n-\n[Enfermedades de las v\u00edas respiratorias](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Respiratory%20Tract%20Diseases)\n-\n[Neumon\u00eda Viral](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pneumonia%2C%20Viral)\n-\n[Neumon\u00eda](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pneumonia)\n-\n[Enfermedades pulmonares](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Lung%20Diseases)\n-\n[Atributos de la enfermedad](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Disease%20Attributes)\n-\n[COVID-19](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=COVID-19)\n-\n[Enfermedades Asintom\u00e1ticas](https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Asymptomatic%20Diseases)\nOtros n\u00fameros de identificaci\u00f3n del estudio\n- AYU/DSSR/02\nPlan de datos de participantes individuales (IPD)\n\u00bfPlanea compartir datos de participantes individuales (IPD)?\nInformaci\u00f3n sobre medicamentos y dispositivos, documentos del estudio\nEstudia un producto farmac\u00e9utico regulado por la FDA de EE. UU.\nEstudia un producto de dispositivo regulado por la FDA de EE. UU.\nEsta informaci\u00f3n se obtuvo directamente del sitio web\n[clinicaltrials.gov](https://clinicaltrials.gov) sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comun\u00edquese con [register@clinicaltrials.gov](mailto:register@clinicaltrials.gov). Tan pronto como se implemente un cambio en [clinicaltrials.gov](https://clinicaltrials.gov), tambi\u00e9n se actualizar\u00e1 autom\u00e1ticamente en nuestro sitio web. .\nEnsayos cl\u00ednicos sobre COVID-19\n-\nNCT06042530ReclutamientoDeterioro Cognitivo | Condici\u00f3n posterior a COVID-19 | Fatiga Mental\n-\nNCT06039449Reclutamiento\n-\nNCT06038617A\u00fan no reclutandoFiebre | Fiebre despu\u00e9s de la vacunaci\u00f3n | Convulsiones Fiebre\n-\nNCT06038682Reclutamiento\n-\nNCT06036134A\u00fan no reclutandoSalud Conocimiento, Actitudes, Pr\u00e1ctica | Pandemia de COVID-19 | Enfermedades prevenibles por vacunaci\u00f3n | Comportamiento relacionado con la salud | Narraci\u00f3n\n-\nNCT06036251A\u00fan no reclutandoEstr\u00e9s | Estr\u00e9s, Emocional | Pandemia de COVID-19 | Reacci\u00f3n de estr\u00e9s\n-\nNCT06030414A\u00fan no reclutando\n-\nNCT06032000A\u00fan no reclutando\n[Un estudio de fase 1 para evaluar la seguridad, reactogenicidad e inmunogenicidad de una vacuna de refuerzo contra el SARS-CoV-2 (LEM-mR203) en adultos sanos](https://ichgcp.net/es/clinical-trials-registry/NCT06032000)Contagio de COVID-19 | Reacci\u00f3n adversa a la vacuna COVID-19\n-\nNCT06027229A\u00fan no reclutando\n[Inmunogenicidad humoral y celular recombinante adicional de COVID-19 en poblaciones inmunodeprimidas](https://ichgcp.net/es/clinical-trials-registry/NCT06027229)COVID-19 | Inmunosupresi\u00f3n\n-\nNCT06027255A\u00fan no reclutandoCOVID largo | Disfunci\u00f3n auton\u00f3mica | POTS - S\u00edndrome de taquicardia ortost\u00e1tica postural\nEnsayos cl\u00ednicos sobre Guduchi Ghan Vati\n-\nNCT04542876Terminado", "language": null, "image": null, "pagetype": "website", "links": ["https://ichgcp.net/es", "#", "https://ichgcp.net/de", "https://ichgcp.net/", "https://ichgcp.net/es", "https://ichgcp.net/fr", "https://ichgcp.net/it", "https://ichgcp.net/pt", "https://ichgcp.net/ru", "https://ichgcp.net/es/guidance-for-industry-investigator-responsibilities-protecting-the-rights-safety-and-welfare-of-study-subjects", "https://ichgcp.net/es/guidance-for-the-notification-of-serious-breaches-of-gcp-or-the-trial-protocol", "https://ichgcp.net/es/national-statement-on-ethical-conduct-in-human-research-2007-updated-2018-nhmrc-australia", "https://ichgcp.net/es/ministerial-ordinance-on-good-clinical-practice-for-drugs-pharmaceuticals-and-medical-devices-agency-japan", "https://ichgcp.net/es/ich-e-group-of-guidelines", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/eu-clinical-trials-registry", "https://ichgcp.net/es/pharma-list", "https://ichgcp.net/es/labs", "https://ichgcp.net/es/service-companies", "https://ichgcp.net/es/events", "https://ichgcp.net/es/clinical-trials-registry/publications", "https://ichgcp.net/es/clinical-trials-registry/researchers", "https://ichgcp.net/es/cra-jobs", "https://ichgcp.net/es/publications", "https://ichgcp.net/es/news", "https://ichgcp.net/clinical-trials-registry/NCT04480398", "https://telegram.me/share/url?url=https://ichgcp.net/es/clinical-trials-registry/NCT04480398&text=", "https://twitter.com/intent/tweet?url=https://ichgcp.net/es/clinical-trials-registry/NCT04480398", "https://ichgcp.net/es", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Aarogyam%20UK", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Covid19", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Asymptomatic%20Condition", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Guduchi%20Ghan%20Vati", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Guduchi%20Ghan%20Vati", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Aarogyam%20UK", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Dr.%20Sarvepalli%20Radhakrishnan%20Rajasthan%20Ayurved%20University", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Samta%20Ayurveda%20Prakoshtha%2C%20India", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=Ayurveda", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=Guduchi%20Ghan%20Vati", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pathologic%20Processes", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Coronavirus%20Infections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Coronaviridae%20Infections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Nidovirales%20Infections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=RNA%20Virus%20Infections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Virus%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Infections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Respiratory%20Tract%20Infections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Respiratory%20Tract%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pneumonia%2C%20Viral", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pneumonia", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Lung%20Diseases", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Disease%20Attributes", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=COVID-19", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Asymptomatic%20Diseases", "https://clinicaltrials.gov", "mailto:register@clinicaltrials.gov", "https://clinicaltrials.gov", "https://ichgcp.net/es/clinical-trials-registry/NCT06042530", "https://ichgcp.net/es/clinical-trials-registry/NCT06039449", "https://ichgcp.net/es/clinical-trials-registry/NCT06038617", "https://ichgcp.net/es/clinical-trials-registry/NCT06038682", "https://ichgcp.net/es/clinical-trials-registry/NCT06036134", "https://ichgcp.net/es/clinical-trials-registry/NCT06036251", "https://ichgcp.net/es/clinical-trials-registry/NCT06030414", "https://ichgcp.net/es/clinical-trials-registry/NCT06032000", "https://ichgcp.net/es/clinical-trials-registry/NCT06027229", "https://ichgcp.net/es/clinical-trials-registry/NCT06027255", "https://ichgcp.net/es/clinical-trials-registry/NCT04542876", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=GlaxoSmithKline", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Kaneka%2BAmericas%2BHolding%2BInc.", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=AstraZeneca", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=European%2BSociety%2Bof%2BHuman%2BReproduction%2Band%2BEmbryology", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Assiut%2BUniversity", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Pediatric%2BOrthopaedic%2BSociety%2Bof%2BNorth%2BAmerica", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Orphanetics%2BPharma%2BEntwicklungs%2BGmbH", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Assistance%2BPublique%2B-%2BH%25C3%25B4pitaux%2Bde%2BParis", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Universidad%2Bdel%2BZulia", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Mayo%2BClinic", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Center%2Bfor%2BIndustrial%2BTechnological%2BDevelopment%2Bof%2BSpain", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Pfizer", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Cairo%2BUniversity", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=M.D.%2BAnderson%2BCancer%2BCenter", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=SeeCure%2BLLC", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Medtronic%2BSurgical%2BTechnologies", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Novartis%2BPharmaceuticals", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Jos%25C3%25A9phine%2BSOLTANI%252C%2BCardiology%2Bdepartment%252C%2BVersailles%2BHospital", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Universidade%2Bde%2BLisboa%252C%2BPortugal", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=National%2BCancer%2BInstitute%2B%2528NCI%2529", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Postneoadjuvant%2BTherapy%2BStage%2BI%2BGastric%2BCancer%2BAJCC%2Bv8", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Ultrasound%2BEvaluation", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stroke", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pain", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Depression", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Malignant%2BNeoplasm%2Bof%2BRespiratory%2Band%2BIntrathoracic%2BOrgan%2BCarcinoma", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Esophageal%2BResection%2BCandidates", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Carcinoma%252C%2BAdrenal%2BCortical", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Breast%2BCancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Asthma", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=HIV%2BInfections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Hypertension", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Obesity", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Post-traumatic%2BAnosmia", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Ankle%2BArthroplasty", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Prostate%2BCancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Coronary%2BArtery%2BDisease", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%2BI%2BGallbladder%2BCancer%2BAJCC%2Bv8", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Cushing%2527s%2BSyndrome%2BI", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colon%2BMalignant%2BTumor", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Cisplatin", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Capecitabine", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=MK-8521%2B100%25CE%25BCg", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Oral%2BGlucose%2BGel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Alpelisib%2B150%2BMG%2BOral%2BTablet%2B%255BPiqray%255D", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Dexamethasone", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Transplant%2B2%2BMelphalan", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Pilocarpine%2B1.25%2525%2BEye%2Bdrop", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Cyclophosphamide", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Docetaxel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Teicoplanin%2BSandoz%2B200%2Bmg%2Bpowder%2Band%2Bsolvent%2Bfor%2Bsolution%2Bfor%2Binjection%2Bor%2Binfusion%2Bor%2Boral%2Bsolution.", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Bevacizumab", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Gemcitabine", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=20mg%2BAzilsartan%2BTablets", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Carboplatin", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Paclitaxel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Brimonidine%2Btartrate%2Bophthalmic%2Bsolution%2B0.025%2525%2B%2528n%2B%253D%2B56%2529", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Prednisone", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Injectafer", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Valacyclovir%2Barrow", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_alpha_all", "https://ichgcp.net/es/cro-list/country/algeria", "https://ichgcp.net/es/cro-list/country/angola", "https://ichgcp.net/es/cro-list/country/colombia", "https://ichgcp.net/es/cro-list/country/djibouti", "https://ichgcp.net/es/cro-list/country/gabon", "https://ichgcp.net/es/cro-list/country/ghana", "https://ichgcp.net/es/cro-list/country/morocco", "https://ichgcp.net/es/cro-list/country/norway", "https://ichgcp.net/es/cro-list/country/poland", "https://ichgcp.net/es/cro-list/country/sri_lanka", "https://ichgcp.net/es/cro-list/country/trinidad_tobago", "https://ichgcp.net/es/cro-list/country/ukraine", "https://ichgcp.net/es/cro-list/country/united_arab_emirates", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/cro-list/country/serbia/company/fidelis_research", "https://ichgcp.net/es/cro-list/country/serbia/company/across_global", "https://ichgcp.net/es/cro-list/country/serbia/company/icon", "https://ichgcp.net/es/cro-list/country/serbia/company/easthorn_clinical_services", "https://ichgcp.net/es/cro-list/country/serbia/company/primevigilance", "https://ichgcp.net/es/cro-list/country/serbia/company/worldwide_clinical_trials", "https://ichgcp.net/es/cro-list/country/serbia/company/parexel", "https://ichgcp.net/es/cro-list/country/serbia/company/sanaclis", "https://ichgcp.net/es/cro-list/country/serbia/company/comac_medical", "https://ichgcp.net/es/cro-list/country/serbia/company/dokumeds", "https://ichgcp.net/es/cro-list/country/serbia", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/ord_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/diet_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/diet_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/locn_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/locn_cat", "https://ichgcp.net/es", "https://ichgcp.net/es/guidance-for-industry-investigator-responsibilities-protecting-the-rights-safety-and-welfare-of-study-subjects", "https://ichgcp.net/es/guidance-for-the-notification-of-serious-breaches-of-gcp-or-the-trial-protocol", "https://ichgcp.net/es/national-statement-on-ethical-conduct-in-human-research-2007-updated-2018-nhmrc-australia", "https://ichgcp.net/es/ministerial-ordinance-on-good-clinical-practice-for-drugs-pharmaceuticals-and-medical-devices-agency-japan", "https://ichgcp.net/es/guideline-for-the-notification-of-serious-breaches-of-regulation-eu-no-536-2014", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/pharma-list", "https://ichgcp.net/es/labs", "https://ichgcp.net/es/service-companies", "https://ichgcp.net/es/cra-jobs", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/eu-clinical-trials-registry", "https://ichgcp.net/es/publications", "https://ichgcp.net/es/news", "https://ichgcp.net/about-us-our-mission", "https://ichgcp.net/es/sitemap", "https://ichgcp.net/es/contact-us", "https://ichgcp.net/es/feed", "/privacy", "/disclaimer", "https://ichgcp.net/da/clinical-trials-registry/NCT04480398", "https://ichgcp.net/de/clinical-trials-registry/NCT04480398", "https://ichgcp.net/clinical-trials-registry/NCT04480398", "https://ichgcp.net/es/clinical-trials-registry/NCT04480398", "https://ichgcp.net/fr/clinical-trials-registry/NCT04480398", "https://ichgcp.net/it/clinical-trials-registry/NCT04480398", "https://ichgcp.net/hu/clinical-trials-registry/NCT04480398", "https://ichgcp.net/nl/clinical-trials-registry/NCT04480398", "https://ichgcp.net/no/clinical-trials-registry/NCT04480398", "https://ichgcp.net/pl/clinical-trials-registry/NCT04480398", "https://ichgcp.net/pt/clinical-trials-registry/NCT04480398", "https://ichgcp.net/fi/clinical-trials-registry/NCT04480398", "https://ichgcp.net/sv/clinical-trials-registry/NCT04480398", "https://ichgcp.net/cs/clinical-trials-registry/NCT04480398", "https://ichgcp.net/ru/clinical-trials-registry/NCT04480398", "https://ichgcp.net/ja/clinical-trials-registry/NCT04480398", "https://ichgcp.net/zh/clinical-trials-registry/NCT04480398", "https://ichgcp.net/ko/clinical-trials-registry/NCT04480398", "https://ichgcp.net/pdf/privacy_cookies_policy.pdf", "https://ichgcp.net/pdf/terms_of_service.pdf", "https://ichgcp.net/pdf/privacy_cookies_policy.pdf", "https://ichgcp.net/pdf/terms_of_service.pdf"]}